• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚维多利亚州与肺癌死亡率相关的患者和地区水平风险因素:贝叶斯空间生存分析。

Patient- and Areal-Level Risk Factors Associated With Lung Cancer Mortality in Victoria, Australia: A Bayesian Spatial Survival Analysis.

机构信息

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

出版信息

Cancer Med. 2024 Oct;13(19):e70293. doi: 10.1002/cam4.70293.

DOI:10.1002/cam4.70293
PMID:39382193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11462597/
Abstract

BACKGROUND

In Australia, lung cancer is the leading cause of cancer-related deaths. In Victoria, the mortality risk is assumed to vary across Local Government Areas (LGAs) due to variations in socioeconomic advantage, remoteness, and healthcare accessibility. Thus, we applied Bayesian spatial survival models to examine the geographic variation in lung cancer survival in Victoria.

METHODS

Data on lung cancer cases were extracted from the Victorian Lung Cancer Registry (VLCR). To account for spatial dependence and risk factors of survival in lung cancer patients, we employed a Bayesian spatial survival model. Conditional Autoregressive (CAR) prior was assigned to model the spatial dependence. Deviance Information Criterion (DIC), Watanabe Akaike Information Criterion (WAIC), and Log Pseudo Marginal Likelihood (LPML) were used for model comparison. In the final best-fitted model, the Adjusted Hazard Ratio (AHR) with the 95% Credible Interval (CrI) was reported. The outcome variable was the survival status of lung cancer patients, defined as whether they survived or died during the follow-up period (death was our interest).

RESULTS

Our study revealed substantial variations in lung cancer mortality in Victoria. Poor Eastern Cooperative Oncology Group (ECOG) performance status, diagnosed at a regional hospital, Small Cell Lung Cancer (SCLC), advanced age, and advanced clinical stage were associated with a higher risk of mortality, whereas being female, presented at Multidisciplinary Team (MDT) meeting, and diagnosed at a metropolitan private hospital were significantly associated with a lower risk of mortality.

CONCLUSION

Identifying geographical disparities in lung cancer survival may help shape healthcare policy to implement more targeted and effective lung cancer care services.

摘要

背景

在澳大利亚,肺癌是导致癌症相关死亡的主要原因。在维多利亚州,由于社会经济优势、偏远程度和医疗保健可及性的差异,预计死亡率在地方政府区域(LGA)之间存在差异。因此,我们应用贝叶斯空间生存模型来研究维多利亚州肺癌生存的地理变化。

方法

从维多利亚肺癌登记处(VLCR)提取肺癌病例数据。为了考虑肺癌患者生存的空间依赖性和风险因素,我们采用了贝叶斯空间生存模型。条件自回归(CAR)先验被分配给模型以模拟空间依赖性。偏差信息准则(DIC)、Watanabe Akaike 信息准则(WAIC)和对数伪边际似然(LPML)用于模型比较。在最终最佳拟合模型中,报告了调整后的风险比(AHR)及其 95%可信区间(CrI)。结局变量是肺癌患者的生存状态,定义为在随访期间是否存活或死亡(死亡是我们关注的)。

结果

我们的研究表明维多利亚州肺癌死亡率存在显著差异。较差的东部合作肿瘤学组(ECOG)表现状态、在地区医院诊断、小细胞肺癌(SCLC)、年龄较大和临床晚期与更高的死亡风险相关,而女性、在多学科团队(MDT)会议上就诊和在大都市私立医院诊断与更低的死亡风险显著相关。

结论

确定肺癌生存的地理差异可能有助于制定医疗保健政策,实施更有针对性和有效的肺癌护理服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/7c4563ffce15/CAM4-13-e70293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/39abe58577b4/CAM4-13-e70293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/412871a82126/CAM4-13-e70293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/7c4563ffce15/CAM4-13-e70293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/39abe58577b4/CAM4-13-e70293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/412871a82126/CAM4-13-e70293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/11462597/7c4563ffce15/CAM4-13-e70293-g003.jpg

相似文献

1
Patient- and Areal-Level Risk Factors Associated With Lung Cancer Mortality in Victoria, Australia: A Bayesian Spatial Survival Analysis.澳大利亚维多利亚州与肺癌死亡率相关的患者和地区水平风险因素:贝叶斯空间生存分析。
Cancer Med. 2024 Oct;13(19):e70293. doi: 10.1002/cam4.70293.
2
Influence of timeliness and receipt of first treatment on geographic variation in non-small cell lung cancer mortality.及时性和首次治疗的获得对非小细胞肺癌死亡率的地理差异的影响。
Int J Cancer. 2021 Apr 15;148(8):1828-1838. doi: 10.1002/ijc.33343. Epub 2020 Oct 21.
3
Bayesian Spatio-Temporal Multilevel Modelling of Patient-Reported Quality of Life following Prostate Cancer Surgery.前列腺癌手术后患者报告的生活质量的贝叶斯时空多水平建模
Healthcare (Basel). 2024 May 26;12(11):1093. doi: 10.3390/healthcare12111093.
4
Association between Receipt of Guideline-Concordant Lung Cancer Treatment and Individual- and Area-Level Factors: A Spatio-Temporal Analysis.符合指南的肺癌治疗的接受情况与个体及地区层面因素之间的关联:一项时空分析。
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2669-2679. doi: 10.1158/1055-9965.EPI-20-0709. Epub 2020 Sep 18.
5
A multi-level spatio-temporal analysis on prostate cancer outcomes.一项关于前列腺癌预后的多层次时空分析。
Cancer Epidemiol. 2021 Jun;72:101939. doi: 10.1016/j.canep.2021.101939. Epub 2021 Apr 13.
6
Mapping Cancer incidence across Western Victoria: the association with age, accessibility, and socioeconomic status among men and women.绘制西维多利亚州癌症发病率图:男性和女性的发病率与年龄、可达性和社会经济地位的关系。
BMC Cancer. 2019 Sep 6;19(1):892. doi: 10.1186/s12885-019-6070-x.
7
Forecasting of Lung Cancer Incident Cases at the Small-Area Level in Victoria, Australia.澳大利亚维多利亚州小区域层面肺癌发病病例预测
Int J Environ Res Public Health. 2021 May 11;18(10):5069. doi: 10.3390/ijerph18105069.
8
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.2011-2019 年维多利亚州小细胞肺癌患者的护理模式:一项回顾性、基于人群的登记数据研究。
Med J Aust. 2023 Aug 7;219(3):120-126. doi: 10.5694/mja2.52017. Epub 2023 Jun 26.
9
Modelling of the time to death of breast cancer patients at Hiwot Fana Specialized University Hospital.Hiwot Fana 专科医院乳腺癌患者死亡时间的建模。
Sci Rep. 2024 Oct 15;14(1):24141. doi: 10.1038/s41598-024-73451-3.
10
Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study.肺癌多学科会议报告的影响:基于人群登记回顾性队列研究的驱动因素和结果。
Lung Cancer. 2022 Jan;163:69-76. doi: 10.1016/j.lungcan.2021.12.006. Epub 2021 Dec 10.

本文引用的文献

1
Lung cancer mortality and associated predictors: systematic review using 32 scientific research findings.肺癌死亡率及相关预测因素:基于32项科研成果的系统评价
Front Oncol. 2023 Dec 14;13:1308897. doi: 10.3389/fonc.2023.1308897. eCollection 2023.
2
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.2011-2019 年维多利亚州小细胞肺癌患者的护理模式:一项回顾性、基于人群的登记数据研究。
Med J Aust. 2023 Aug 7;219(3):120-126. doi: 10.5694/mja2.52017. Epub 2023 Jun 26.
3
Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021.
澳大利亚基于医院的多学科肺癌治疗:2021 年的现状调查。
BMJ Open Respir Res. 2022 Jan;9(1). doi: 10.1136/bmjresp-2021-001157.
4
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050.2020 年和 2050 年全球、区域和国家肺癌发病率、死亡率和死亡率与发病率比的制图。
Int J Clin Oncol. 2022 Apr;27(4):665-675. doi: 10.1007/s10147-021-02108-2. Epub 2022 Jan 12.
5
Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study.肺癌多学科会议报告的影响:基于人群登记回顾性队列研究的驱动因素和结果。
Lung Cancer. 2022 Jan;163:69-76. doi: 10.1016/j.lungcan.2021.12.006. Epub 2021 Dec 10.
6
Factors associated with early lung cancer mortality: a systematic review.与早期肺癌死亡率相关的因素:系统评价。
Expert Rev Anticancer Ther. 2021 Oct;21(10):1125-1133. doi: 10.1080/14737140.2021.1941888. Epub 2021 Jun 30.
7
Forecasting of Lung Cancer Incident Cases at the Small-Area Level in Victoria, Australia.澳大利亚维多利亚州小区域层面肺癌发病病例预测
Int J Environ Res Public Health. 2021 May 11;18(10):5069. doi: 10.3390/ijerph18105069.
8
Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?老年肺癌患者的超额死亡率和治疗不足:现代社会中的治疗虚无主义?
ERJ Open Res. 2021 May 24;7(2). doi: 10.1183/23120541.00393-2020. eCollection 2021 Apr.
9
Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.帕博利珠单抗单药治疗晚期非小细胞肺癌患者的表现状态与生存的关系。
JAMA Netw Open. 2021 Feb 1;4(2):e2037120. doi: 10.1001/jamanetworkopen.2020.37120.
10
Small-cell lung cancer.小细胞肺癌。
Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0.